Can Gevo Survive Big Oil's Lawyers?

Synthetic biology company Gevo is developing a technology platform that converts sugars into isobutanol. The four-carbon molecule has several big advantages over ethanol -- a two-carbon molecule -- including higher energy density, the potential to be a drop-in fuel compatible with current infrastructure, and the ability to be transformed into higher-value chemicals such as plastics and rubbers. When accounting for its potential in petrochemicals and specialty chemicals the global isobutanol market weighs in at over 70 billion gallons per year -- three times larger than the global ethanol market -- before accounting for fuels.

There is a pretty big prize awaiting the first handful of companies that can establish themselves in the industry. Unfortunately, the race for that prize also leads to cutthroat competition. Gevo has been embroiled in a fierce legal battle with Butamax, a joint venture between BP and DuPont that is seeking to develop its own isobutanol platform, for several years.

While Gevo recently won a major preliminary court decision over Butamax that will protect its technology, investors can expect a lengthy appeals process to weigh on shares. Fool.com contributor Maxxwell Chatsko explains the latest developments and what it means for investors.

Are you part of the 99%? The Motley Fool's new free report highlights three less-than-luxurious stocks the 1% may be overlooking. Just click here to read it now.

The article Can Gevo Survive Big Oil's Lawyers? originally appeared on Fool.com.

Erin Miller has no position in any stocks mentioned. Motley Fool contributor Maxx Chatsko has no position in any stocks mentioned. Check out his personal portfolio, his CAPS page, or follow him on Twitter @BlacknGoldFool to keep up with his writing on energy, bioprocessing, and emerging technologies.The Motley Fool recommends Coca-Cola. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.